Delivery Order SPE2DE24D0013-SPE2D625F4HDC
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $27,650.40 firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with completion targeted for September 25, 2025. The delivery order, identified as XPRSMVP-10 (Contract Number 4569505244), is being performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents a discrete procurement under the company's broader federal contracting relationship with...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a firm fixed-price delivery order valued at $3,708.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation. This award represents a discrete delivery order under one of Cepheid's larger indefinite delivery vehicle contracts with the...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $5,520 firm fixed-price delivery order to Cepheid Inc. on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order, designated XPRSTREPA-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The contract represents a procurement of molecular diagnostic solutions from Cepheid, a specialized manufacturer of advanced...
- The Defense Logistics Agency (DLA), under the Medical Supply Chain program, awarded a delivery order valued at $1,648.38 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on August 12, 2025. This firm fixed-price delivery order, without set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare agencies. The contract is scheduled for ultimate completion by August 19, 2025,...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $4,568.25 to Cepheid Inc. on August 25, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $26,627.40 delivery order (XPRSMVP-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with a completion date of September 26, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the agency's procurement of diagnostic testing solutions from Cepheid, a company specializing in advanced molecular diagnostic systems and...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,595.60 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a task order under one of Cepheid's existing indefinite delivery vehicle contracts that enables the federal government to procure molecular diagnostic...
- The U.S. Defense Logistics Agency (DLA), operating through its Medical Supply Chain division, awarded a $28,786 firm fixed-price delivery order to Cepheid Inc. on September 4, 2025, with completion scheduled for September 11, 2025. This non-set-aside contract is issued under Cepheid's existing Indefinite Delivery Vehicle (IDV) with the Veterans Integrated Service Network (VISN) 6, a $32.8 million single-award contract that extends through September 30, 2030. The work will be performed at...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F4HDCDelivery Order
The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $52,387.20 to Cepheid Inc. on September 26, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order (contract number 4569624736, XPRS4PLEX-10) carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The award represents a discrete purchase under one of Cepheid's larger indefinite delivery vehicles, likely drawing from the company's established IDV contract with the VA's Veterans Integrated Service Network for molecular diagnostic testing systems, reagents, and assays. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in advanced diagnostic systems and test kits for infectious disease detection and clinical testing. The company has established itself as a critical supplier to federal healthcare systems, including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency, with a primary focus on delivering GeneXpert diagnostic systems and related molecular testing capabilities for conditions such as COVID-19, influenza, RSV, and other infectious diseases. This delivery order continues Cepheid's consistent support of federal diagnostic infrastructure through firm fixed-price procurement arrangements that enable rapid deployment of testing solutions across the defense health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.4k | 9/26/25 |